COVID-19 and Gynecological Cancers: A Summary of International Recommendations
- PDF / 548,174 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 1 Downloads / 195 Views
COVID-19
COVID-19 and Gynecological Cancers: A Summary of International Recommendations Nabil Ismaili 1,2
&
Sanaa Elmajjaoui 3
Accepted: 20 August 2020 # Springer Nature Switzerland AG 2020
Abstract Morocco and the rest of the world are experiencing a pandemic of a new coronavirus known as COVID-19 or SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On August 24, 2020, the spread of the virus in Morocco had caused more than 52,000 cases and 880 deaths. Cancer patients are more susceptible to develop an infection than people without cancer because of their immunosuppression caused by the disease and treatments (surgery and chemotherapy). Therefore, these patients are at higher risk of infection with COVID-19 and a much higher risk of developing more serious forms. Given this epidemiological context, the establishment of guidelines for patients with gynecological cancers, requiring multidisciplinary management during the global COVID-19 pandemic, is crucial to limit their infection while maintaining their chances for a cure. In this paper, we summarize the international COVID-19 recommendations on the prioritization of surgical cases, the perioperative protective measures, the precautions to be taken in the brachytherapy unit, the COVID-19 screening, and finally the therapeutic indications of gynecological cancers by tumor location. Keywords COVID-19 . Gynecologic cancers . Surgery . Chemotherapy . Radiotherapy . Prioritization . Recommendations
Introduction Morocco and the rest of the world are experiencing a pandemic of a new coronavirus known as COVID-19 or SARS-CoV2 (severe acute respiratory syndrome coronavirus 2) [1]. On August 22, 2020, the spread of the virus in Morocco had caused more than 52,000 cases and 880 deaths. Cancer patients are more susceptible to develop an infection than people without cancer because of their immunosuppression caused by the disease and treatments, such as
This article is part of the Topical Collection on COVID-19 * Nabil Ismaili [email protected]; [email protected] Sanaa Elmajjaoui [email protected] 1
Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
2
Department of Medical Oncology, Cheick Khalifa International University Hospital, Casablanca, Morocco
3
Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco
chemotherapy and/or surgery. Therefore, these patients are at higher risk of infection with COVID-19 and a much higher risk of developing more serious forms [1]. Given this epidemiological context, it is important to establish recommendations that may still offer these patients effective treatment while at the same time limit their exposure and infection with the virus. In fact, a recent Turkish study of 200 patients who received surgery for gynecological cancers during the COVID-19 pandemic showed that gynecological cancer surgery can be performed safely when appropriate measures to protect patients and staff from the exposure to COVID-19 are taken pre
Data Loading...